Latest debt-to-equity ratio
TransCode Therapeutics Debt-to-equity ratio
Direct answer
TransCode Therapeutics's debt-to-equity ratio is 0.47%.
The verified market snapshot reports 0.47%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 12, 2026.
Get free TransCode Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.47%
Explore related company data
View TransCode Therapeutics's market capitalizationView TransCode Therapeutics's return on equityView TransCode Therapeutics's dividend yieldView TransCode Therapeutics's 52-week price rangeView TransCode Therapeutics's profit marginView all TransCode Therapeutics key metricsReturn to TransCode Therapeutics profile